Pandemic Leaves Medtech With $500bn In M&A Firepower

EY’s M&A Firepower report predicts very active M&A activity for medtechs in 2021, driven by diagnostics and digital health, but with some headwinds remaining.

merger and acquisition business concepts, join company on puzzle pieces, 3d rendering

Despite a challenging year with many COVID-19-related interruptions, medtech companies’ deal-making “firepower” is at an all-time high, which positions the sector well for a very active mergers and acquisitions market in 2021, according to EY’s recent M&A Firepower report.

In spite of many procedures getting postponed due to COVID-19 in 2020, medtech’s firepower, which EY defines as a company’s...

More from Business Strategy

More from In Vivo